000 01476 a2200385 4500
005 20250514063815.0
264 0 _c20031124
008 200311s 0 0 eng d
022 _a0007-1188
024 7 _a10.1038/sj.bjp.0705163
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOrdan, Orly
245 0 0 _aStress-responsive JNK mitogen-activated protein kinase mediates aspirin-induced suppression of B16 melanoma cellular proliferation.
_h[electronic resource]
260 _bBritish journal of pharmacology
_cMar 2003
300 _a1156-62 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnticarcinogenic Agents
_xmetabolism
650 0 4 _aAspirin
_xpharmacology
650 0 4 _aCell Death
_xdrug effects
650 0 4 _aDrug Synergism
650 0 4 _aGenes, jun
_xdrug effects
650 0 4 _aHumans
650 0 4 _aJNK Mitogen-Activated Protein Kinases
650 0 4 _aMAP Kinase Kinase 4
650 0 4 _aMelanoma, Experimental
_xpathology
650 0 4 _aMitogen-Activated Protein Kinase Kinases
_xmetabolism
650 0 4 _aOrganophosphates
_xmetabolism
650 0 4 _aSuppression, Genetic
_xdrug effects
650 0 4 _aTumor Cells, Cultured
700 1 _aRotem, Ronit
700 1 _aJaspers, Ilona
700 1 _aFlescher, Eliezer
773 0 _tBritish journal of pharmacology
_gvol. 138
_gno. 6
_gp. 1156-62
856 4 0 _uhttps://doi.org/10.1038/sj.bjp.0705163
_zAvailable from publisher's website
999 _c12476399
_d12476399